Washington University in St Louis (WUSTL) has just received a $2M research grant that will go towards combating a disorder which afflicts, often fatally, nearly 5.8 million Americans each year: heart failure. Heart failure is one of the leading causes of death in the US and although many promising drugs have been introduced over the years, we have yet to find a definitive treatment for the variety of cases that doctors encounter. This $2M NIH award wil go to a team of WUSTL scientists for basic research that will contribute to our understanding of heart disease and ideally lead to more effective treatment. The end goal of this research project is the design and construction of artificial tissue models of the heart, which will allow scientists to more quickly and efficiently test new drugs.
Science Market Update
Tags: Bioscience research, Midwest, biomedical sciences, biomedical research, Bioresearch, Washington University, Missouri, WUSTL, heart disease, 2012, Biochemistry, BioResearch Product Faire Event, Research, Research, NIH, MO, St Louis, BRPF, basic research funding
At the University of Pennsylvania, Steve Fluharty is the senior vice provost for research, as well as a professor and researcher himself in the School of Veterinary Medicine. Now he's got one more hat to wear, as a member of the selection committee for the newly-announced Golden Goose Awards, sponsored by a congressional committee and supported by the AAAS and a broad base of other organizations and industry. At a time when basic research in particular is hard-tasked to justify its continued funding, the point of the awards is to look positively at the sometimes-serendipitous nature of scientific progress so as not to "kill the golden goose" (that lays the golden eggs), which all variations on the ancient fable agree is a really bad idea. Wikipedia says of the phrase: It is generally used of a short-sighted action that destroys the profitability of an asset. Exactly.